As new omicron subvariants of COVID-19 continue to sweep across the United States, researchers at the University of Missouri have identified specific mutations within the virus’ spike protein that help omicron subvariants evade existing antibodies humans have from either vaccines or previous COVID-19 infections. These mutations help explain why some people are continuing to test positive for the coronavirus, which, like most viruses, continues to evolve.